Published in J Biol Chem on October 02, 1998
Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett (2009) 1.31
Inhibition of phosphatidylcholine synthesis induces expression of the endoplasmic reticulum stress and apoptosis-related protein CCAAT/enhancer-binding protein-homologous protein (CHOP/GADD153). Biochem J (2003) 1.22
Farnesol is utilized for isoprenoid biosynthesis in plant cells via farnesyl pyrophosphate formed by successive monophosphorylation reactions. Proc Natl Acad Sci U S A (1999) 1.14
Caspase processing and nuclear export of CTP:phosphocholine cytidylyltransferase alpha during farnesol-induced apoptosis. Mol Cell Biol (2002) 1.00
Complementary transcriptomic, lipidomic, and targeted functional genetic analyses in cultured Drosophila cells highlight the role of glycerophospholipid metabolism in Flock House virus RNA replication. BMC Genomics (2010) 0.99
Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann Clin Microbiol Antimicrob (2009) 0.97
Farnesol-induced cell death and stimulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in tobacco cv bright yellow-2 cells. Plant Physiol (2000) 0.93
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br J Cancer (2006) 0.91
Vitamin E analogues as inducers of apoptosis: structure-function relation. Br J Cancer (2003) 0.89
Nuclear export of the rate-limiting enzyme in phosphatidylcholine synthesis is mediated by its membrane binding domain. J Lipid Res (2008) 0.86
Enteropathogenic Escherichia coli infection triggers host phospholipid metabolism perturbations. Infect Immun (2004) 0.85
Induction of apoptosis by lipophilic activators of CTP:phosphocholine cytidylyltransferase alpha (CCTalpha). Biochem J (2005) 0.83
A mechanism for suppression of the CDP-choline pathway during apoptosis. J Lipid Res (2013) 0.81
Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1. Vasc Cell (2012) 0.80
In vitro assessment of choline dihydrogen phosphate (CDHP) as a vehicle for recombinant human interleukin-2 (rhIL-2). Cell Mol Bioeng (2012) 0.79
Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7. J Biol Inorg Chem (2009) 0.79
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Pharmacol Exp Ther (2007) 0.79
Pterodon pubescens seed extract induces the cell cycle arrest of leukemic cells by deregulating cyclin D1 and E2 mRNA levels. Oncol Lett (2010) 0.77
A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis. Biochem J (2002) 0.77
Impaired geranylgeranyltransferase-I regulation reduces membrane-associated Rho protein levels in aged mouse brain. J Neurochem (2014) 0.75
Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase. Exp Biol Med (Maywood) (2013) 0.75
Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res (2000) 2.42
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 1.97
A genetic defect in phosphatidylcholine biosynthesis triggers apoptosis in Chinese hamster ovary cells. J Biol Chem (1996) 1.52
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant (2002) 1.46
Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J Biol Chem (2000) 1.27
The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci (2005) 1.26
HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ (2011) 1.23
Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. BMC Cancer (2006) 1.22
GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Cancer Res (1997) 1.11
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem (2000) 1.10
RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody. Proc Natl Acad Sci U S A (2000) 1.07
Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Cell Death Differ (2009) 1.04
In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther (2008) 1.02
Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cell Mol Life Sci (2006) 0.99
Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Ther (1998) 0.99
Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer (1993) 0.97
Biodistribution study of 99mTc-labeled LDL in B16-melanoma-bearing mice. Visualization of a preferential uptake by the tumor. Int J Cancer (1993) 0.97
Phosphatidylcholine cycle and regulation of phosphatidylcholine biosynthesis by enzyme translocation. Biochim Biophys Acta (1994) 0.96
Inhibition of human tumor cell growth in vitro and in vivo by a specific inhibitor of human farnesyltransferase: BIM-46068. Int J Cancer (1999) 0.96
Indium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. Bioconjug Chem (1996) 0.93
Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression. FASEB J (2005) 0.92
New insight on the molecular mechanisms of high-density lipoprotein cellular interactions. Cell Mol Life Sci (2004) 0.91
Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma. Ann Oncol (2005) 0.90
Tumor incidence in related hematopoietic stem cell donors. Bone Marrow Transplant (2010) 0.89
Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells. Cancer Res (1992) 0.88
Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells. Cancer Res (1997) 0.87
Serum protein signature may improve detection of ductal carcinoma in situ of the breast. Oncogene (2009) 0.87
Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells. Biochem Biophys Res Commun (1999) 0.87
Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie (1993) 0.86
Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochem Biophys Res Commun (1996) 0.86
Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab? Bone Marrow Transplant (2008) 0.85
[Cardiac metastasis of renal cell carcinoma, a rare location]. Prog Urol (2011) 0.85
Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice. Br J Cancer (1993) 0.85
Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication. Cell Death Differ (2005) 0.84
The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Cancer Gene Ther (2000) 0.84
Epstein-Barr virus-associated hepatic leiomyosarcoma after renal transplantation: case report. Transplant Proc (2010) 0.83
[Diagnosis and treatment of the encrusted cystitis]. Actas Urol Esp (2010) 0.82
The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B. Biochemistry (1988) 0.81
Analysis of hydrophilic and lipophilic choline compounds in radioresistant and radiosensitive glioblastoma cell lines by HILIC-ESI-MS/MS. Anal Bioanal Chem (2010) 0.81
A new family of potential oncostatics: 2-chloroethylnitrososulfamides (CENS)--I. Synthesis, structure, and pharmacological evaluation (preliminary results). Bioorg Med Chem (1996) 0.81
Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro. Biochem Pharmacol (1990) 0.81
Thyroid hormone residues are released from thyroglobulin with only limited alteration of the thyroglobulin structure. J Biol Chem (1989) 0.80
Synthesis and application of a N-1' fluorescent biotinyl derivative inducing the specific carboxy-terminal dual labeling of a novel RhoB-selective scFv. Bioconjug Chem (2009) 0.80
Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis. J Clin Chem Clin Biochem (1986) 0.80
Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV). Biochim Biophys Acta (1997) 0.79
Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation. Bone Marrow Transplant (1999) 0.79
[Development of farsenyl transferase inhibitors as anticancer agents]. Ann Pharm Fr (2005) 0.78
Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants. Bone Marrow Transplant (2000) 0.78
Identification of an ApoA-I ligand domain that interacts with high-affinity binding sites on HepG2 cells. Biochem Biophys Res Commun (2000) 0.78
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS. Radiat Res (1999) 0.78
Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol (2000) 0.78
Enhancement of anti-tumor immunity by injection of fibroblasts genetically engineered to produce IL-12 and to express CD70. Adv Exp Med Biol (1998) 0.78
Characterization of two high-density lipoprotein binding sites on porcine hepatocyte plasma membranes: contribution of scavenger receptor class B type I (SR-BI) to the low-affinity component. Biochemistry (2000) 0.78
Phosphatidylcholine turnover in activated human neutrophils. Agonist-induced cytidylyltransferase translocation is subsequent to phospholipase D activation. J Biol Chem (1995) 0.78
Subcellular localization of phospholipids and enzymes involved in PAF-acether metabolism. J Cell Biochem (1989) 0.77
Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency. Br J Haematol (1999) 0.77
Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody. Br J Cancer (1996) 0.77
Tender Nesting Polypore (Hapalopilus rutilans) poisoning: report of two cases. Clin Toxicol (Phila) (2013) 0.77
Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro. Eur J Cancer Clin Oncol (1989) 0.77
Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells. Biochem J (1998) 0.77
Involvement of tyrosine kinase activity in the low-density lipoprotein receptor expression in human lung adenocarcinoma cell line A549. Biochimie (1996) 0.77
Reversion of transformed phenotype of human adenocarcinoma A549 cells by expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase complementary DNA. Cell Growth Differ (1995) 0.77
Cell-cell interactions in the process of differentiation of thyroid epithelial cells into follicles: a study by microinjection and fluorescence microscopy on in vitro reconstituted thyroid follicles. J Cell Physiol (1990) 0.76
Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma. Cancer Gene Ther (2008) 0.76
Evidence for qualitative abnormalities in high-density lipoproteins from myeloma patients: the presence of amyloid A protein could explain HDL modifications. Biochim Biophys Acta (1988) 0.76
SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression. Br J Cancer (1998) 0.75
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood. Int J Lab Hematol (2009) 0.75
Involvement of the Ca(2+)-dependent phosphorylation of a 20 kDa protein in the proliferative effect of high-density lipoproteins (subclass 3) on the adenocarcinoma cell line A549. Biochem J (1995) 0.75
[Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia]. Ann Biol Clin (Paris) (1985) 0.75
Reversible dissociation of cortisol-transcortin complex by sodium para-chloromercuribenzoate. Biochim Biophys Acta (1983) 0.75
[Determination of cerebrospinal fluid proteins using the Cobas Fara centrifugal analyser. Adaptation of the turbidimetric technic to benzethonium chloride]. Ann Biol Clin (Paris) (1990) 0.75
[Cachexia, ascites and kidney failure]. Praxis (Bern 1994) (1996) 0.75
Preferential cytoplasmic localization of p34cdc2 in recurrent human squamous cell carcinoma after radiotherapy. Radiat Res (1997) 0.75
Double allogeneic peripheral stem cell transplants for patients at high risk of relapse. Bone Marrow Transplant (1998) 0.75
Physico-chemical properties and evidence for electrophoretic variants of rat transcortin. Biochimie (1984) 0.75
[Vectorization of antineoplastic drugs by low density lipoproteins: incorporation of acyl celiptium and metabolism of complexes in the cellular receptor of human fibroblasts]. Bull Cancer (1989) 0.75
Interaction between radiomimetic drugs and rat plasma lipoproteins. Role of cyclophosphamide and chloromethin. J Pharmacol (1983) 0.75
Abnormal lactate dehydrogenase isoenzyme pattern in serum of a patient with a testicular tumor. Clin Chem (1992) 0.75
[Injectable anti-cancer drugs. Stocking, preparation and administration]. Soins (1990) 0.75
[Acupunctural analgesia in labor. Preliminary study]. J Gynecol Obstet Biol Reprod (Paris) (1976) 0.75
[Anaphylactic shock: a severe emergency in allergology]. Soins (1980) 0.75
A sensitive immunochemiluminescence assay for human serum amyloid A protein. Clin Biochem (1991) 0.75
[25 years allogenic bone marrow transplantation in Basel: 1973-1998]. Schweiz Med Wochenschr (1998) 0.75
Quantitative abnormalities of lipoprotein particles in multiple myeloma. J Clin Chem Clin Biochem (1987) 0.75
[Arterial lesions occurring in the course of trauma of the extremities]. Ann Chir (1966) 0.75
Premenstrual syndrome and atopy: a double-blind clinical evaluation of treatment with a gamma-globulin/histamine complex. Pharmatherapeutica (1980) 0.75
Treatment choice in psychiatry? Would trainees choose similar treatments to those prescribed, and what influences decision-making? A survey of the European Federation of Trainees' (EFPT) Research Group. Acta Neuropsychiatr (2009) 0.75
[Plasma lipoproteins and multiple myeloma. Variations of lipid constituents of HDL and apolipoproteins A1 and B]. Ann Biol Clin (Paris) (1983) 0.75